Board of Directors
rule

About Us | Board of Directors | Staff | Acknowledgments | Legal Information | Press Releases | Contact Us

Anand Mahdevan, M.D.


Anand Mahadevan, MD completed his general surgical and oncology residency in the United Kingdom followed by a fellowship at Beth Israel Deaconess Medical Center (BIDMC) in the Harvard Radiation Oncology Program (HROP). He is currently Chair of the department of Radiation Oncology at Geisinger Health Systems in Danville, Pennsylvania. Other than CNS malignancies, Dr. Mahadevan has had a particular interest in SBRT for liver/pancreas tumors and oligometastases. Anand joined the Board in 2012 and currently serves as the Chairman of the Board of Directors.

Richard D. Bucholz, M.D.

Richard Donald Bucholz attended Yale College, receiving a bachelor in science Cum Laude in molecular biochemistry and biophysics in 1973. He continued at Yale for his medical education and completed a general surgical internship and neurosurgical residency at Yale New Haven Medical Center. He was an Instructor at Yale in 1982-83 before accepting a position of assistant professor at Saint Louis University School of Medicine under Dr. Kenneth R. Smith, Jr. He was certified by the American Board of Neurological Surgery in 1985, and became a full professor in 1996. He is  Professor and Vice Chairman of the Department of Neurosurgery and continues his entrepreneurial interest in medical technology. Dr. Bucholz holds a total of 22 patents and others are pending. He is a Fellow of the American College of Surgeons and is a member of numerous medical societies, and has been involved with the Radiosurgery Society for many years and currently serves as President.

Shalom Kalnicki, M.D.

Shalom Kalnicki is Professor and Chairman of the Department of Radiation Oncology at Montefiore Medical Center and Albert Einstein College of Medicine. A physician leader, researcher and teacher, Dr. Kalnicki leads an internationally recognized radiation oncology department since July 2004, when he rejoined the ranks of Montefiore-Einstein.

Throughout his career, Dr. Kalnicki has focused on researching and implementing new technologies in the radiation treatment of cancer. He pioneered the use of intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), target motion management with 4-D radiation planning, stereotactic body radiation therapy (SBRT) and functional tumor imaging with PET-CT fusion techniques. His research has implications for radiation treatment planning and techniques used for most clinical situations in radiation oncology, including brain, head and neck, thoracic, upper abdominal and pelvic malignancies. His research interests also include quality-of-life issues such as socio-economic disparities in radiation oncology and the impact of family caregiver support on patients’ compliance. In April 2016 Dr. Kalnicki was elected as President-Elect of the Board of Directors.

John J. Kresl, M.D., Ph.D., DABR, FACRO

John Kresl completed advanced medical educational and research training in the field of oncology as a National Institute of Health (N.I.H.) supported combined MD/PhD Fellow in Graduate Medical Science training in Molecular and Immunological Tumor Cell Biology, culminating in a Doctor of Philosophy Degree from Northwestern University Graduate School, Evanston, Illinois. In addition to basic science training, Dr. Kresl completed his clinical medical training, receiving a Medical Doctorate Degree from Northwestern University Medical School in Chicago, Illinois. In addition to remaining active in Oncology research, Dr. Kresl is very involved in clinical practice in radiation oncology for all tumor sites. Dr. Kresl has been the principal investigator and co-investigator on dozens of clinical protocols and has published over 150 abstracts, manuscripts and book chapters related to radiation oncology, including editing the first two textbooks on Robotic Radiosurgery. He frequently is an invited lecturer on these topics around the world. Dr. Kresl is Board Certified by the American Board of Radiology in Radiation Oncology. He joined the Board of Directors of the Radiosurgery Society in 2007 and currently serves as Treasurer.

Najeeb Mohideen, M.D.


Dr. Mohideen, a member of the Radiosurgery Society since 2006, is a Radiation Oncologist at Northwest Community Hospital in Arlington Heights, Illinois. He has held many leadership positions in Radiation Oncology. He has served on the Board of Directors of the American Society for Radiation Oncology (ASTRO) and has also chaired its Health Policy Council. He currently serves on ASTRO’s Health Policy Committee and Payment Reform Workgroup and is Chair of the Radiation Oncology Economics Committee for the American College of Radiology. Dr. Mohideen joined the Board of Directors in March 2015. In April 2016 Dr. Mohideen became Secretary of the Board of Directors.

Hale Basak Özkök Çaglar, M.D.

Hale Basak Özkök Çaglar is an Associate Professor of Radiation Oncology and head of the department at Medipol University Hospital, Istanbul, Turkey. From 1998 – 2006 she worked in the Gamma Knife Unit of the neurosurgery department at Marmara University, the first Gamma Knife site in Turkey. During her fellowship at Brigham and Women’s Hospital and Dana Farber Cancer Institute, Harvard University in Boston, she worked in thoracic and head and neck oncology and was introduced to and worked with Novalis. Upon her return to Turkey she focused on neuro-oncology, Gamma Knife, thoracic oncology and pediatric tumors. In 2010 while at Acibadem University and Acibadem Maslak Hospital, Istanbul Dr. Caglar was introduced to the CyberKnife and Trilogy Linac. In late 2012 she became the director of Medipol University Hospital Radiation Oncology Department and Gamma Knife Unit with neurosurgery.

Andrew Gaya, BSc, MD, MRCP, FRCR


Andy Gaya gained his MD in London, England in 1995, where he was awarded a distinction and several academic prizes. Dr. Gaya treats gastrointestinal tumours using chemotherapy, radiotherapy, immunotherapy and biological therapies. His dual specialty training in medical and radiation oncology gives him a very balanced perspective into the multimodality nature of modern cancer therapy. His major academic interests are in the areas of functional cancer imaging, immunotherapy and stereotactic body radiotherapy. He has been at the forefront of the implementation of the latest radiotherapy techniques in the UK. He was one of the first UK doctors to use both CyberKnife and Tomotherapy, and is co-editing a major textbook of stereotactic radiotherapy. Dr. Gaya is a Consultant Clinical Oncologist at Guy's & St Thomas' NHS Foundation Trust and the London Oncology Clinic. He joined the RSS board in January 2014.

Iris C. Gibbs, M.D., FACR

Iris C. Gibbs, MD, FACR, Associate Professor of Radiation Oncology and Associate Dean of MD Admissions at Stanford Medicine. Dr. Gibbs’ clinical and research expertise are pediatric and adult brain tumors, and robotic radiosurgery. As former Co-Director of Stanford CyberKnife Radiosurgery program, Dr. Gibbs contributed to building world- renowned clinical programs in innovative radiation treatment of central nervous system tumors and robotic radiosurgery. Dr. Gibbs has served as committee chair for the Radiosurgery Society (formerly CyberKnife Society) and is a dedicated member of the International Stereotactic Radiosurgery Society (ISRS).

In 2014, Dr. Gibbs was appointed as Associate Dean for Medical School Admissions of Stanford Medicine. She is a 2015 Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Fellow and a fellow of the American College of Radiology. In addition to leadership service roles for Radiological Society of North America (RSNA), American Society of Radiation Oncology (ASTRO), and the American Board of Radiology (ABR), Dr. Gibbs is the current vice chair of the Section on Radiology for the National Medical Association. Dr. Gibbs became a board member in April 2016.

Michael Schulder, M.D.


Dr. Schulder is vice chair, residency program director, and professor of neurosurgery at the Hofstra North Shore LIJ School of Medicine. He also serves as the Director of the Brain Tumor Center, and the Co-Director of the Center for Stereotactic Radiosurgery at North Shore LIJ. Mike has been a member of the Radiosurgery Society since 2003 (Member #20). He trained in SRS at the University of Florida and at the Brigham and Women's Hospital and has practiced it for over 20 years. Dr. Schulder's experience includes treating patients with the X-Knife, Cyberknife, Novalis, Varian, and Gamma Knife systems. He believes strongly that SRS programs and indeed the entire field are best advanced by surgical specialists working together with radiation oncologists. Dr. Schulder joined the Board of Directors in March 2015.

Ben J. Slotman, MD, PhD


Ben J. Slotman received his MD (1985) and PhD (1990) both cum laude at the VU University in Amsterdam, The Netherlands. He was registered as radiation oncologist in 1994. In 1998 he was appointed full professor of Radiation Oncology and Chair of the department at VU University. Since 2005 he is also chairman of one of the six divisions of the university medical center. He is co-chair of the Cancer Center Amsterdam (VUMC CCA). Ben Slotman is also board member of the International Society of Radiosurgery (ISRS) and president-elect of the American Radium Society. He has (co)-authored about 300 peer-reviewed publications and coordinated a number of trials, including the EORTC study on PCI in ES-SCLC and the C-REST trial on the role of thoracic irradiation in these patients. His further research activities are concentrated on intra- and extracranial stereotactic radiotherapy and the introduction of new technologies in radiotherapy, most recently stereotactic MRI-guided and adaptive radiotherapy (SMART). Professor Slotman joined the RSS Board of Directors in February 2016.

Jun Yang, Ph.D.


Jun Yang Ph.D. is chief physicist at the Philadelphia CyberKnife.  He is a member of the AAPM Task Group #135 and serves on the Physics Committee for the Radiosurgery Society. As an adjunct clinical associate professor of Drexel University, he has authored and co-authored many publications on medical physics with emphasis on Robotic Radiosurgery technology. Jun joined the Physics Committee in 2011, the RSS Board of Directors in 2012 and as of January 2013 serves as the chairman of the Physics Committee.
Member login  
rule

ABSTRACT SUBMISSION DEADLINE
Saturday, April 1, 2017



   
the RSS would like to
acknowledge and thank our 
Corporate Sponsors.

    

the RSS would like to 
acknowledge and thank our 
Academic & Hospital and
Free-Standing & Private Practice
Sponsors.






  
the RSS is pleased to collaborate with the following:







Interact With Us!
facebook Like our Facebook Page   
Join our Facebook Group
twiter Follow us on Twitter 
Follow our Group on LinkedIn
Visit our Journal on Cureus
Skype Me™!  Call us on Skype
divider